Penta at IAS 2019

17 Jul, 2019

We are delighted to announce that the 10th International AIDS Society Conference on HIV Science has accepted two presentations of interest to the Penta network. The IAS Conference is the world’s most influential meeting on HIV research and its applications. Gathering more than 5,000 participants from over 140 countries, IAS 2019 in Mexico City will present the most critical advances in basic, clinical and operational HIV research that moves science into policy and practice.

Pablo Rojo will present a poster on behalf of the EPIICAL consortium at both ‘IAS 2019’ and the pre-meeting ‘2019 HIV & HBV Cure Forum’. The poster, co-authored with Caroline Foster, will focus on the key CARMA study within the project. During the sessions he will illustrate the main factors associated with low viral reservoir in a large multi-centre cohort of early treated children infected with HIV on sustained suppressive ART for more than a decade.

Meanwhile, Hylke Waalewijn will deliver a late breaker oral presentation on the Penta sponsored study ODYSSEY (PENTA 20), more specfically on the PK substudy nested within the trial. Hylke is currently working as a PhD student at the Radboud Institute for Health Sciences in Nijmegen, The Netherlands. His research focuses on the pharmacokinetics of antiretroviral drugs, specifically in HIV infected children.

Furthermore, the IAS affiliated independent event ‘11th International Workshop on HIV Paediatrics 2019‘ on 19 – 20 July will host a series of other presentations by members of the Penta network. Martina Penazzato will provide an update on What’s New from WHO on Paediatric Antiretroviral Therapy. Penta board member Claire Thorne will deliver an Update on Preconception ARVs and Birth Defects. In addition to these, two oral abstract presentations will also talk place: Lizzie Chappell of the MRC CTU at UCL, and on behalf of EPPICC, will speak on Malignancies in Children With HIV Across Eastern and Western Europe and Thailand, whereas Siobhan Crichton, also working at the MRC CTU at UCL, will speak on Virological Outcomes and ART Discontinuation in Children Switching to Dolutegravir in The UK/Ireland: A Propensity Score Analysis. Siobhan will also present a poster on the key CHIPS study during the Paediatric Antiretroviral Drugs poster walk: Children and Adolescents in the UK/ Ireland CHIPS Cohort on Integrase Inhibitors: Safety and Effectiveness.

You can find more information on IAS 2019 on the official website.